KUUR THERAPEUTICS
Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.
KUUR THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2005-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.kuurtx.com
Total Employee:
51+
Status:
Active
Contact:
44 20 7554 4070
Email Addresses:
[email protected]
Total Funding:
191.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty AdBlock Acceptable Ads Bodis DNS
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-06-20 | CGT Catapult | CGT Catapult acquired by Kuur Therapeutics | N/A |
| 2016-07-12 | Delenex Therapeutics | Delenex Therapeutics acquired by Kuur Therapeutics | N/A |
Investors List
Hambro Perks Ltd.
Hambro Perks Ltd. investment in Secondary Market - Kuur Therapeutics
Invesco Perpetual
Invesco Perpetual investment in Series C - Kuur Therapeutics
Touchstone Innovations
Touchstone Innovations investment in Series C - Kuur Therapeutics
Woodford Investment Management
Woodford Investment Management investment in Series C - Kuur Therapeutics
Imperial Innovations
Imperial Innovations investment in Series B - Kuur Therapeutics
Invesco
Invesco investment in Series B - Kuur Therapeutics
Woodford Investment Management
Woodford Investment Management investment in Series B - Kuur Therapeutics
Wellcome Trust
Wellcome Trust investment in Venture Round - Kuur Therapeutics
Invesco
Invesco investment in Venture Round - Kuur Therapeutics
Imperial Innovations
Imperial Innovations investment in Venture Round - Kuur Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-11 | In search of a Kuur: Cell Medica rebrands and regroups, taking a new name, a new CEO and new money |
Official Site Inspections
http://www.kuurtx.com Semrush global rank: 6.43 M Semrush visits lastest month: 1.02 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
